Kinetic analysis of reversible inhibition of 16α- hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization0

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 6, 2003, Pages 890-892

  Numazawa, Mitsuteru ^a   Mutsumi, Ayako ^a   Tachibana, Mii ^a   Yoshimura, Akiko ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

16 hydroxyandrostenedione aromatization; Binding site; Human placental aromatase; Reversible inhibition; Suicide substrate

Indexed keywords

10BETA ACETOXYANDROST 5 EN 7,17 DIONE; 16ALPHA HYDROXYANDROSTENEDIONE; 19 HYDROXYANDROSTENEDIONE; ANDROST 5 ENE 4,7,17 TRIONE; ANDROSTENEDIONE; ANDROSTENEDIONE DERIVATIVE; FORMESTANE; SUICIDE SUBSTRATE; UNCLASSIFIED DRUG;

AROMATIZATION; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME MECHANISM; ENZYME SPECIFICITY; HUMAN; HUMAN TISSUE; KINETICS; MICROSOME; PLACENTA;

EID: 10644239093     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.890     Document Type: Article

References (23)

1. Thompson E. A., Jr., Siiteri P. K., J. Biol. Chem., 249, 5373-5378 (1974).
2. Kellis J. T., Jr., Vickery L. E., J. Biol. Chem., 262, 4413-4420 (1987).
3. Yoshida N., Osawa Y., Biochemistry, 30, 3003-3010 (1991).
4. Ryan K. J., "Maternal-Fetal Endocrinology," ed. by Tulchinsky D., Ryan K. J., W. S. Saunders Company, Philadelphia, 1980, pp. 3-6.
5. For example, see Johnson J. O., Crit. Rev. Biochem. Mol. Biol., 33, 375-405 (1998).
6. Brodie A. M. H., Garrett W. M., Hendrickson J. R., Tsai-Morris C. H., Marcotte P. A., Robinson C. H., Steroids, 38, 693-702 (1981).
7. Covey D. F., Hood W. F., Endocrinology, 108, 1597-1599 (1981).
8. Numazawa M., Mutsumi A., Hoshi K., Kigawa M., Oshibe M., J. Steroid Biochem. Mol. Biol., 39, 959-966 (1991).
9. Numazawa M., Tachibana M., Tateda Y., J. Steroid Biochem. Mol. Biol., 58, 431-438 (1996).
10. Numazawa M., Tachibana M., Steroids, 62, 516-522 (1997).
11. Numazawa M., Tachibana M., Mutsumi A., Yoshimura A., Osawa Y., J. Steroid Biochem. Mol. Biol., 81, 165-172 (2002).
12. Canick J. A., Ryan K. J., Mol. Cell. Endocrinol., 6, 105-115 (1976).
13. Cantineau R., Kremers P., De Graeve J., Gielen J. E., Lambotte R., J. Steroid Biochem., 16, 157-163 (1982).
14. Purohit A., Oakey R. E., J. Steroid Biochem. Mol. Biol., 33, 439-448 (1989).
15. Numazawa M., Mutsumi A., Nakakoshi M., Nagaoka M., Chem. Pharm Bull., 40, 1839-1842 (1992).
16. Ryan K. J., J. Biol. Chem., 234, 268-272 (1959).
17. Siiteri P. K., Thompson E. A., Jr., J. Steroid Biochem., 6, 317-322 (1975).
18. GraFit version 5-0.3, Erithacus Software Limited, Surrey, UK, 2001
19. Simpson E., Lauber M., Demeter M., Stirling D., Rodgers R., Means G., Mahendroo M., Kilgore M., Mendelson C., Waterman M., J. Steroid Biochem. Mol. Biol., 40, 45-52 (1991).
20. Numazawa M., Mutsumi A., J. Steroids Biochem. Mol. Biol., 44, 199-201 (1993).
21. Numazawa M., Midzuhashi K., Nagaoka M., Biochem. Pharmacol., 47, 717-726 (1994).
22. Numazawa M , Mutsumi A., Tachibana M., Biochem. Pharmacol , 52, 1253-1259 (1996).
23. Furth P. S., Rosenberger J., Marcotte P. A , Robinson C. H., J Enzyme Inhibition, 4, 131-135 (1990).